Dexcom (NSDQ:DXCM) said today that its G6 continuous glucose monitoring system will be covered for Medicare beneficiaries.
The company’s product won coverage as a therapeutic CGM system, making it available to beneficiaries who closely manage their insulin dosing.
Get the full story at our sister site, Drug Delivery Business News.
The post Dexcom wins CMS nod for latest glucose monitor appeared first on MassDevice.
from MassDevice https://ift.tt/2yLurBo
Cap comentari:
Publica un comentari a l'entrada